$10,000 award to recognize outstanding efforts to advance apheresis and patient care
LAKEWOOD, Colo., USA—31 March 2014—Terumo BCT is seeking applicants for a new $10,000 award to support the advancement of apheresis and patient care. Through this grant, Terumo BCT will recognize and support the efforts of clinicians, physicians and operators who are furthering the practice of therapeutic apheresis and cell collections.
Tom Jordan, Executive Vice President, Global Commercial Operations, Terumo BCT
"Together with our customers, Terumo BCT is advancing apheresis to ultimately benefit the patients we all serve. With this award, we support the efforts of those making a difference in the practice of apheresis. We look forward to learning more about those organizations in our global community who are showing this significant influence in their daily endeavors."
About Terumo BCT
Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction technologies. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.
Sherri Hughes-Smith, Terumo BCT Global Integrated Communications
Products available in select markets.